Evigrade
Major

celecoxib × Ketorolac

Selective COX-2 inhibitor (coxib)×Non-steroidal anti-inflammatory drugs (NSAIDs)

Mechanism

Dual NSAID therapy – additive GI bleeding, nephrotoxicity, and cardiovascular event risks. Ketorolac itself is limited to 5 days of use.

Symptoms

Black or tarry stools (melena), vomiting blood or coffee-ground material, epigastric pain. Risk multiplies in older patients and with prior peptic ulcer disease.

Management

The combination is not prescribed. One NSAID at a time. For enhanced analgesia, add paracetamol or a short opioid course, not a second NSAID.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions